Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for ICON PLC (ICLR : NSDQ)

• Company Description    ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. Number of Employees: 38,330

• Price / Volume Information    Yesterday's Closing Price: $209.15 Daily Weekly Monthly 20 Day Moving Average: 517,027 shares Shares Outstanding: 81.39 (millions) Market Capitalization: $17,022.72 (millions) Beta: 0.97 52 Week High: $313.00 52 Week Low: $199.01 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -15.52% -7.80% 12 Week -5.04% -0.03% Year To Date -32.47% -21.28%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL SOUTH COUNTY BUSINESS PARK LEOPARDSTOWN - DUBLIN,L2 00000 IRL ph: 353-1291-2000 fax: 353-1247-6260 None http://www.iconplc.com

• General Corporate Information    Officers Steve Cutler - Chief Executive Officer Ciaran Murray - Chairman Brendan Brennan - Chief Financial Officer John Climax - Director Joan Garahy - Director Peer Information ICON PLC (CHCR) ICON PLC (ESRX) ICON PLC (MYDP) ICON PLC (GBCS) ICON PLC (LAXAF) ICON PLC (IPCM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: G4705A100 SIC: 8731 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 07/20/22 Share - Related Items Shares Outstanding: 81.39 Most Recent Split Date: 8.00 (2.00:1) Beta: 0.97 Market Capitalization: $17,022.72 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $2.52 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $10.67 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 18.24% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 07/20/22

• Fundamental Ratios P/E Current FY Estimate: 19.60 Trailing 12 Months: 21.54 PEG Ratio: 1.07 Price Ratios Price/Book: 2.11 Price/Cash Flow: 18.25 Price / Sales: 2.61 EPS Growth vs. Year Ago Period: 26.21% vs. Previous Quarter: 6.56% Sales Growth vs. Year Ago Period: 121.60% vs. Previous Quarter: 0.88% ROE 03/31/22 - 11.33 12/31/21 - 12.71 09/30/21 - 15.50 ROA 03/31/22 - 5.31 12/31/21 - 6.04 09/30/21 - 7.59 Current Ratio 03/31/22 - 1.13 12/31/21 - 1.19 09/30/21 - 1.36 Quick Ratio 03/31/22 - 1.13 12/31/21 - 1.19 09/30/21 - 1.36 Operating Margin 03/31/22 - 11.35 12/31/21 - 11.59 09/30/21 - 12.26 Net Margin 03/31/22 - 2.58 12/31/21 - 2.79 09/30/21 - 4.09 Pre-Tax Margin 03/31/22 - 3.21 12/31/21 - 3.59 09/30/21 - 5.09 Book Value 03/31/22 - 99.14 12/31/21 - 99.11 09/30/21 - 97.91 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.63 12/31/21 - 0.67 09/30/21 - 0.74 Debt-to-Capital 03/31/22 - 38.67 12/31/21 - 40.01 09/30/21 - 42.43

Powered by Zacks Investment Research ©